VERO Stock Catalyst: Venus Concept Secures $23.24M Bridge Financing and European Patent Grant

Apr 7, 2025 · 3:59pm ET

Venus Concept Inc. received a decision to grant European Patent Number EP3542745.

Max move

+51.4%

High of day $3.60

Sparker timei

3:59pm ET

VERO · Apr 7, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Venus Concept Inc. (VERO) announced on April 4, 2025, that it has secured bridge financing of up to $23.24 million from Madryn Health Partners. The financing includes multiple drawdowns, with an initial drawdown of $2 million under the Loan and Security Agreement to support general working capital and ongoing operations. Additionally, the company has received a decision to grant European Patent Number EP3542745 titled 'DEVICE FOR FRACTIONAL RF TREATMENT OF THE SKIN (TO IMPROVE APPEARANCE)'.

The total bridge financing amount is $23.24 million, with an initial drawdown of $2 million. The European patent grant enhances the company's intellectual property portfolio.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time VERO sparks.

Download Sniper App →

Catch the next VERO-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →